Bruker Corp. Aktie
32,03 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -0,32 % | -6,89 % | -10,94 % | -29,21 % | -22,53 % | - | - |
| Healthequity Inc. | -0,75 % | 3,91 % | 0,00 % | -28,11 % | -14,74 % | 4,72 % | -0,75 % |
| Omnicell Inc. | -2,81 % | 2,89 % | 9,20 % | 4,09 % | -8,25 % | -32,19 % | -65,44 % |
| Myriad Genetics | -1,82 % | 13,40 % | 2,80 % | -53,93 % | -16,98 % | -78,70 % | -81,40 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




